GTR 118680134

Tenders Are Invited For Pharmaceutical Products – Delivery Of Medicinal Products From The Group: Medicines Available Under The Drug Program; Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition; Anticancer And Immunomodulatory Drugs And Non-Specific Immunoglobulins (According To The Atc Classification) – From A List Of 31 Packages

ICB — International Competitive Bid Closed central europe
Tender Information
GTR Reference
118680134
Tendering Authority
Subscribe to view
Tender No
666516-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Delivery Of Medicinal Products From The Group: Medicines Available Under The Drug Program; Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition; Anticancer And Immunomodulatory Drugs And Non-Specific Immunoglobulins (According To The Atc Classification) – From A List Of 31 Packages
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
central europe
Political Region
European Union
Last Date of Bid Submission
06-10-2026 Closed
Work Detail
Pharmaceutical Products – Delivery Of Medicinal Products From The Group: Medicines Available Under The Drug Program; Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition; Anticancer And Immunomodulatory Drugs And Non-Specific Immunoglobulins (According To The Atc Classification) – From A List Of 31 Packages. Mitomycinum,Durvalumab,Daunorubicine,Glophitamabum,Thalidomidum,Tacrolimusum,Tacrolimusum,Regorafenibum,Trastuzumab Deruxtecan,Tebentafuspum,Sacituzumabum Govitecanum,Ramucirumabum,Polatuzumabum Vedotinum,Peginterferonum Alfa-2A,Nintedanibum,Mycophenolate Mofetil,Lorlatinibum,Immunoglobulins Intravenous, Solution 10%, Igg Content ≥ 98%, Iga Content ≤ 0.025 Mg/Ml,Immunoglobulins Intravenous, Solution 10%, Igg Content ≥ 98%, Iga Content ≤ 0.14 Mg/Ml,Denosumabum,Denosumabum,Landumumabum,Darolutamidum,Cytarabine,Cemiplimabum,Cabozantinibum,Azacitidine,Alpelisibum,Netupitanum + Palonosetroni Hydrochloricum,Propofolum,Belantamab Mafodotin
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
77751a60-23e4-4ec1-84cb-5f7f43c66ecb.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you